SCM
LUNG icon

Soleus Capital Management’s Pulmonx LUNG Stock Holding History

Soleus Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.6M Buy
2,788,323
+750,000
+37% +$1.24M 0.15% 72
2025
Q4 		$4.5M Buy
+2,038,323
New +$3.83M 0.19% 70
2023
Q3 		– Sell
-41,000
Closed -$538K – 106
2023
Q2 		$538K Sell
41,000
-30,000
-42% -$367K 0.06% 94
2023
Q1 		$794K Hold
71,000
– – 0.1% 73
2022
Q4 		$599K Buy
+71,000
New +$675K 0.09% 68
2021
Q4 		– Sell
-87,612
Closed -$3.15M – 83
2021
Q3 		$3.15M Buy
87,612
+2,362
+3% +$92.9K 0.49% 50
2021
Q2 		$3.76M Buy
+85,250
New +$3.71M 0.58% 36

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $10.1B AUM 30.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return